Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells

被引：10
|
作者：
Banoth, Balaji [1 ]
Cassel, Suzanne L. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA 90048 USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2017年 / 140卷 / 04期
基金：
美国国家卫生研究院;
关键词：
Nucleotide-binding leucine-rich repeat receptor family pyrin domain containing protein 3; Bruton tyrosine kinase; ibrutinib;
D O I：
10.1016/j.jaci.2017.03.041
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：985 / 987
页数：3
相关论文
共 50 条
  • [21] Bruton's Tyrosine Kinase Inhibition in Pemphigus: An Embattled Frontier
    Payne, Aimee S.
    Vieira, Silvio Manfredo
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (08) : 1667 - 1670
  • [22] Bruton's Tyrosine Kinase Inhibition for the Treatment of Rheumatoid Arthritis
    Arneson, Laura C.
    Carroll, Kristen J.
    Ruderman, Eric M.
    IMMUNOTARGETS AND THERAPY, 2021, 10 : 333 - 342
  • [23] Bruton's tyrosine kinase inhibition for the treatment of allergic disorders
    Lin, Erica V.
    Suresh, Ragha V.
    Dispenza, Melanie C.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (01) : 33 - 42
  • [24] Ibrutinib inhibition of Bruton protein-tyrosine kinase (BTK) in the treatment of B cell neoplasms
    Roskoski, Robert, Jr.
    PHARMACOLOGICAL RESEARCH, 2016, 113 : 395 - 408
  • [25] Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia Beyond Ibrutinib
    Lasica, Masa
    Tam, Constantine S.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2021, 35 (04) : 761 - 773
  • [26] Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors A Review
    Dybowski, Sarah
    Torke, Sebastian
    Weber, Martin S.
    JAMA NEUROLOGY, 2023, 80 (04) : 404 - 414
  • [27] Targeting Bruton's tyrosine kinase in B cell malignancies
    Rudi W. Hendriks
    Saravanan Yuvaraj
    Laurens P. Kil
    Nature Reviews Cancer, 2014, 14 : 219 - 232
  • [28] Bruton's Tyrosine Kinase (BTK) Inhibitors in Clinical Trials
    Burger, Jan A.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2014, 9 (01) : 44 - 49
  • [29] Bruton's tyrosine kinase inhibition suppresses pathological retinal angiogenesis
    Chen, Siyue
    Liu, Yuming
    Zhang, Yutian
    Guo, Xu
    Bai, Tinghui
    He, Kai
    Zhu, Yanfang
    Lei, Yi
    Du, Mei
    Wang, Xiaohong
    Liu, Qiang
    Yan, Hua
    BRITISH JOURNAL OF PHARMACOLOGY, 2024,
  • [30] The emerging role of Bruton's tyrosine kinase inhibition in urticaria management
    Lauletta, Giuseppe
    Potestio, Luca
    Patruno, Cataldo
    Cantelli, Mariateresa
    Napolitano, Maddalena
    EXPERT OPINION ON DRUG SAFETY, 2025,
12345